Agenus | Capital Ordinário



Ordinary Share Capital Alterar Data
AbbVie USD 18M 0 2024-12
Amgen USD 33.58B 45M 2025-03
AstraZeneca USD 388M 0 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Celldex Therapeutics USD 66K 0 2025-03
CSL USD 576M 19M 2024-12
Dynavax Technologies USD 124K 1000 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 193K 0 2025-03
J&J USD 3.12B 0 2025-03
Jiangsu Hengrui CNY 6.38B 0 2025-03
MacroGenics USD 628K 1000 2024-12
Merck EUR 565M 397M 2025-03
Merck USD 1.79B 0 2025-03
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Veracyte USD 78K 0 2025-03



Agenus Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.